Search Results - "Brazzell, R K"

Refine Results
  1. 1

    Periocular Injection of Microspheres Containing PKC412 Inhibits Choroidal Neovascularization in a Porcine Model by Saishin, Yoshitsugu, Silva, Raquel Lima, Saishin, Yumiko, Callahan, Kevin, Schoch, Christian, Ahlheim, Markus, Lai, Hong, Kane, Frances, Brazzell, R. K, Bodmer, David, Campochiaro, Peter A

    “…Oral administration of PKC412, a kinase inhibitor that blocks several isoforms of protein kinase C (PKC) and receptors for vascular endothelial growth factor…”
    Get full text
    Journal Article
  2. 2

    Sustained transduction of ocular cells with a bovine immunodeficiency viral vector by Takahashi, Kyoichi, Luo, Tianci, Saishin, Yoshitsugu, Saishin, Yumiko, Sung, Jennifer, Hackett, Sean, Brazzell, R K, Kaleko, Michael, Campochiaro, Peter A

    Published in Human gene therapy (20-07-2002)
    “…Human immunodeficiency viral (HIV) vectors mediate long-term transduction of many types of nondividing cells in vivo. Bovine immunodeficiency virus (BIV) is a…”
    Get more information
    Journal Article
  3. 3

    Human recombinant epidermal growth factor in experimental corneal wound healing by Brazzell, RK, Stern, ME, Aquavella, JV, Beuerman, RW, Baird, L

    “…Human recombinant epidermal growth factor (hEGF) was evaluated in various corneal wound healing models in the rabbit. Human EGF accelerated epithelial wound…”
    Get full text
    Journal Article
  4. 4

    Interspecies comparison of the pharmacokinetics of aldose reductase inhibitors by Brazzell, R K, Park, Y H, Wooldridge, C B, McCue, B, Barker, R, Couch, R, York, B

    Published in Drug metabolism and disposition (01-07-1990)
    “…The pharmacokinetics of three aldose reductase inhibitors (ARIs) were evaluated in various species, including rat, dog, cynomolgus monkey, rhesus monkey,…”
    Get more information
    Journal Article
  5. 5

    Pharmacokinetics of isotretinoin during repetitive dosing to patients by Brazzell, R K, Vane, F M, Ehmann, C W, Colburn, W A

    Published in European journal of clinical pharmacology (01-01-1983)
    “…The multiple dose pharmacokinetics of isotretinoin and its major blood metabolite, 4-oxo-isotretinoin, were studied in 10 patients with cystic acne and 11…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Disposition of the aldose reductase inhibitor AL01576 in rats by Park, Y H, Wooldridge, C B, Mattern, J, Stoltz, M L, Brazzell, R K

    Published in Journal of pharmaceutical sciences (01-02-1988)
    “…The disposition of the aldose reductase inhibitor AL01576 was studied in rats following intravenous and oral dosing. Single 4-mg/kg intravenous bolus and oral…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Saturable tissue binding and imirestat pharmacokinetics in rats by CHIEN, J. Y, BANFIELD, C. R, BRAZZELL, R. K, MAYER, P. R, SLATTERY, J. T

    Published in Pharmaceutical research (01-04-1992)
    “…To investigate the hypothesis that the pharmacokinetics of imirestat, an aldose reductase inhibitor, are influenced by saturable binding to tissues, three…”
    Get full text
    Journal Article
  10. 10

    Age and cibenzoline disposition by Brazzell, R K, Rees, M M, Khoo, K C, Szuna, A J, Sandor, D, Hannigan, J

    Published in Clinical pharmacology and therapeutics (01-11-1984)
    “…Oral cibenzoline kinetics were followed in 36 healthy subjects aged from 22 to 78 yr divided into groups of six subjects per decade between 20 and 80 yr. Each…”
    Get more information
    Journal Article
  11. 11

    Single-dose pharmacokinetics and dose proportionality of oral cibenzoline by Khoo, K C, Szuna, A J, Colburn, W A, Aogaichi, K, Morganroth, J, Brazzell, R K

    Published in Journal of clinical pharmacology (01-07-1984)
    “…The pharmacokinetics of cibenzoline were evaluated in four young healthy volunteers who received ascending oral doses of 65, 97.5, 130, 162.5, 195, 227.5, and…”
    Get more information
    Journal Article
  12. 12

    Dose-dependent pharmacokinetics of the aldose reductase inhibitor imirestat in man by BRAZZELL, R. K, MAYER, P. R, DOBBS, R, MCNAMARA, P. J, RENLI TENG, SLATTERY, J. T

    Published in Pharmaceutical research (1991)
    “…The pharmacokinetics of imirestat were studied in healthy volunteers following single and multiple oral doses. After single doses of 20 to 50 mg, imirestat…”
    Get full text
    Journal Article
  13. 13

    Pharmacokinetics of the aldose reductase inhibitor imirestat following topical ocular administration by BRAZZELL, R. K, WOOLDRIDGE, C. B, HACKETT, R. B, MCCUE, B. A

    Published in Pharmaceutical research (01-02-1990)
    “…The pharmacokinetics of imirestat following topical ocular administration were evaluated in a series of studies in rabbits and dogs. Following single topical…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Pharmacokinetics and pharmacodynamics of intravenous cibenzoline in normal volunteers by Brazzell, R K, Khoo, K C, Szuna, A J, Sandor, D, Aogaichi, K, Wills, R J

    Published in Journal of clinical pharmacology (01-09-1985)
    “…The pharmacokinetics of intravenous (IV) cibenzoline were studied in six healthy male volunteers ranging in age from 51 to 78 years. The subjects received…”
    Get more information
    Journal Article
  16. 16

    Topical and systemic absorption of sodium pyrithione following topical application to the nails of the rhesus monkey by Mayer, P R, Couch, R C, Erickson, M K, Wooldridge, C B, Brazzell, R K

    Published in Skin pharmacology (01-01-1992)
    “…A study was performed to investigate the local penetration into the nail, the systemic absorption into the rest of the body, and the routes of excretion of…”
    Get more information
    Journal Article
  17. 17

    Cibenzoline plasma concentration and antiarrhythmic effect by Brazzell, R K, Aogaichi, K, Heger, Jr, J J, Somberg, J C, Carliner, N H, Morganroth, J

    Published in Clinical pharmacology and therapeutics (01-03-1984)
    “…The relationship between plasma concentrations of cibenzoline and its antiarrhythmic effect was evaluated in patients receiving the drug orally as part of an…”
    Get more information
    Journal Article
  18. 18

    Effect of time of dosing on the disposition of oral cibenzoline by Brazzell, R K, Khoo, K C, Schneck, D W

    Published in Biopharmaceutics & drug disposition (01-10-1985)
    “…Single oral doses of cibenzoline were administered to eight healthy volunteers on two different occasions, once at 8.00 am and once at 10.00 pm, in a…”
    Get more information
    Journal Article
  19. 19

    Pharmacokinetic and pharmacodynamic modeling of cibenzoline plasma concentrations and antiarrhythmic effect by Holazo, A A, Brazzell, R K, Colburn, W A

    Published in Journal of clinical pharmacology (01-05-1986)
    “…The plasma concentration and antiarrhythmic effect data following multiple, ascending oral doses of cibenzoline in four patients with frequent premature…”
    Get more information
    Journal Article
  20. 20

    Verapamil pharmacodynamics after intravenous and oral dosing: theoretic consideration by Colburn, W A, Brazzell, R K, Holazo, A A

    Published in Journal of clinical pharmacology (01-01-1986)
    “…Differences in the potency of intravenous (IV) and oral verapamil have recently been reported with the concentration-response curve for PR-interval…”
    Get more information
    Journal Article